The Pyrazolo[3,4-d]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of NeuroblastomaEnrico Rango(University of Siena), Maurizio Botta(University of Siena)BiomedicinesMarch 12, 202210.3390/biomedicines10030659Cited by 10SaveCiteExport RISWatch citationsRelated PapersToward the Discovery of Novel Anti‐HIV Drugs. Second‐Generation Inhibitors of the Cellular ATPase DDX3 with Improved Anti‐HIV Activity: Synthesis, Structure–Activity Relationship Analysis, Cytotoxicity Studies, and Target Validation|ChemMedChem|2011|105Discovery of Chiral Cyclopropyl Dihydro-Alkylthio-Benzyl-Oxopyrimidine (<i>S</i>-DABO) Derivatives as Potent HIV-1 Reverse Transcriptase Inhibitors with High Activity Against Clinically Relevant Mutants|Journal of Medicinal Chemistry|2009|38Novel Sulfamide-Containing Compounds as Selective Carbonic Anhydrase I Inhibitors|Molecules|2017|31